Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
{{output}}
Introduction: Memantine is a noncompetitive N-methyl-D-aspartate receptor antagonist approved by the FDA for moderate to severe Alzheimer's dementia. Memantine is also recommended as an off-label treatment in current catatonia c... ...
